Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS)

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 69, Issue 2, 1996, Pages 83-89

  Schaefer, Christof ^a   Amoura Elefant, Elisabeth ^b   Vial, Thierry ^c   Ornoy, Asher ^d   Garbis, Hanneke ^e   Robert, Elisabeth ^f   Rodriguez Pinilla, Elvira ^g   Pexieder, Tomas ^h   Prapas, Nikos ⁱ   Merlob, Paul ^j  

^a Abt Embryotoxikologie der L   (Germany)

^b Section of Radiology   (France)

^c Pharmaco Toxicovigilance et Ctr A   (France)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f Institut Europeen des Genomutations   (France)

^g SCHOOL OF MEDICINE   (Spain)

^h Institut d'Histologie et d'Embryologie   (Switzerland)

ⁱ Dept of Obstetrics and Gynecology ^*  (Greece)

^j RABIN MEDICAL CENTER   (Israel)

more..

Author keywords

pregnancy; prospective follow up study; quinolones

Indexed keywords

CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN;

ARTICLE; CONGENITAL MALFORMATION; DATA ANALYSIS; DRUG SAFETY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL RECORD; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; TERATOGENICITY; THERAPEUTIC ABORTION; TREATMENT PLANNING;

EID: 0030296712     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(95)02524-3     Document Type: Article

References (17)

1. [1] Bach C, López E, Sabriá J. Defectos congénitos de la pared abdominal poco frequentes. A propósito de dos casos en los que se constata la exposición embrionaria precoz a las quinolonas (english abstract). Progresos Diagnóstico Prenatal 1993; 5: 13-7.
2. [2] Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G. Safety of the New Quinolones in Pregnancy. Obstet Gynecol 1994; 84: 535-8.
3. [3] Bomford JAL, Ledger JC, O'Keefe BJ, Reiter C. Ciprofloxacin use during pregnancy. Drugs 1993; 45: 461-2.
4. [4] Peled Y, Friedman S, Hod M, Merlob P. Ofloxacin during the second trimester of pregnancy. DICP, Ann Pharmacother 1991; 25: 1181-2.
5. [5] Giamarellou H, Kolokythas E, Petrikkos G, Gazis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989; 87 (5A): 49s-51s.
6. [6] Mitelman F, Kolnig AM, Strombeck B, Norrby R, Wadstein J. No cytogenetic effects of quinolone treatment in humans. Antimicrob Agents Chemother 1988; 32: 936-7.
7. [7] Pino A, Mauro A, Villa F, Masciangelo L. Evaluation of DNA damage induced by norfloxacin in liver and kidney of adult rats and in fetal tissues after transplacental exposure. Mutat Res 1991; 264: 81-5.
8. [8] Cukierski MA, Prahalada S, Zacchei AG et al. Embryotoxicity studies of Norfloxacin in Cynomolgus monkeys: I Teratology studies and Norfloxacin plasma concentration in pregnant and nonpregnant monkeys. Teratology 1989; 39: 39-52.
9. [9] Hummler H, Richter WF, Hendrick AG. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (macaca fascicularis). Toxicol Appl Pharmacol 1993; 122: 34-45.
10. [10] Sato T, Kobayashi F. Teratological study on cinoxacin in rabbits. Chemotherapy 1980; 28: 508-75.
11. [11] Schlüter G. Ciprofloxacin: toxicologic evaluation of additional safety data. Am J Med 1989; 87 (5A): 37s-9s.
12. [12] Gough AW, Kasali OB, Sigler RE, Baragi V. Quinolone arthropathy - acute toxicity to immature articular cartilage. Toxicol Pathol 1992; 20: 436-49.
13. [13] Stahlmann R, Förster C, Van Sickle D. Quinolomes in children. Drug Saf 1993; 9: 397-403.
14. [14] Garbis JM, Robert E, Peters PWJ. Experience of two Teratology Information Services in Europe. Teratology 1990; 42: 629-34.
15. [15] Schaefer C, Vennewald F. FETIS - a documentation and follow up program for cooperation between Teratology Information Services. Teratology 1993; 47: 435.
16. [16] Källén B. Epidemiology of Human Reproduction. Boca Raton: CRC 1988.
17. [17] The International Clearinghouse for Birth Defects Monitoring Systems. Congenital malformations worldwide. Amsterdam: Elsevier 1991.